Promising Future for Ex vivo Tissue Fabrication. Eiji Kobayashi, MD, PhD Department of Organ Fabrication, Keio University School of Medicine, Japan

Similar documents
Stem Cell Principle -

Stem Cells: Ethics and Oversight May 24, Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center

The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017

CENTER FOR BRAIN EXPERIMENT

Stem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean?

Des cellules-souches dans le poumon : pourquoi faire?

Relative cost of hepatocytes

Recent advances in tissue-engineered corneal regeneration

Embryonic development, epigenics and somatic cell nuclear transfer - The science and its social implications -

Stem Cell Services. Driving Innovation for Stem Cell Researchers

Primary Mouse Embryonic Fibroblast Isolation Kit

Developmental Biology 3230 Exam 1 (Feb. 6) NAME

From Stem Cell to Any Cell

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications

V4: cellular reprogramming

Bioreactors in tissue engineering

Stem Cells. for Journalists, Policymakers, and Campaigns

DEPArray Technology. Sorting and Recovery of Rare Cells

Patient Handbook on Stem Cell Therapies

Scientists have successfully used stem cells to reverse this paralysis. Magnification 0.02

Stem cells and motor neurone disease

Wider Adoption of Regenerative Medicine Driven by Open Innovation

Soryong (Ryan) Chae Department of Biomedical, Chemical, and Environmental Engineering

Recent Progress in ips Cell Research and Application

Best Practices Maintaining Pluripotency. Anne R. Greenlee, PhD

PTH Effects Bone Healing and Vasculogenesis in Calvaria Bone Allograft Model

Stem Cells and Cell Culture Developments Within ThermoFisher Scientific

Chapter 8 Cell Diversity

ADVANCED MEDIA TECHNOLOGY

C-type natriuretic peptide signalling and cardiovascular disease Adrian Hobbs

Artery-on-a-Chip: A Microfluidic Platform to Investigate Small Artery Function

Smooth Muscle-Specific Expression of ipla 2 β Participates in the Initiation and Early Progression of Vascular Inflammation and Neointima Formation

SI8000 Live Cell Imaging System

Recommendation. Genome Editing Technology in Medical Sciences and Clinical Applications in Japan. September 27, 2017 Science Council of Japan

Should Embryonic Stem Cell Research be Permitted to Continue? Over the past few years a debate has been going on over the moral implications of

Extrapolation of in vitro effects to in vivo embryotoxicity Basic requirements for prediction model development. Han van de Sandt, PhD

CRISPR Applications: Mouse

Medicyte GmbH. Infinity Gets Cultured. European Business Development Conference, Dresden October 2014 Björn F. Lindemann, CEO

Nanotechnology and Advanced Materials for more effective Healthcare

Stem Cells: A Primer National Institutes of Health

REPORT OF THE IBC WORKING GROUP ON HUMAN CLONING AND INTERNATIONAL GOVERNANCE

FREQUENTLY ASKED QUESTIONSON STEM CELLS AND THEIR CLINICAL APPLICATIONS/THERAPY

Nucleofector Technology in. Somatic Stem Cell Research. gene transfer begins here

Eric W. Abelquist, Ph.D., CHP President, Health Physics Society. August 2017

Immunogenicity of Stem Cells in Therapeutic Applications. MDPB-Registry meeting nov 25th Stem cell immunogenicity in therapeutic applications

Cor.At. Cardiomyocytes derived from Mouse Embryonic Stem Cells. Protocol. Cor.At Cardiomyocytes Transfection

APPLICATION NOTE Rev. 7/2017, v4.0 Fluorescent Nanodiamonds: Bio-applications. Physical and Fluorescence Properties

Stony Brook University Human Stem Cell Research Policy (August 15, 2013 version)

Supplementary Figure Legend

Genome Editing Technology - Principle -

5.5. Multicellular Life. Multicellular organisms depend on interactions among different cell types.

ReproRNA -OKSGM is a non-integrating, self-replicating RNA-based reprogramming vector for generating induced pluripotent stem (ips)

Human Embryonic Stem Cell and covered Human Pluripotent Stem Cell Research Operating Procedures

With a lot of TLC and ingenuity, Eric Lagasse is growing working livers in lymph nodes. 18 PITTMED

Contains Nonbinding Recommendations Draft - Not for Implementation

Syringe Pumps. Please contact us for help in selecting the best pump for your application and a free quote.

Stem Cells for the Future Treatment of Parkinson's Disease

Insight to Gene Techno Science Co.,Ltd

Gaussia Luciferase-a Novel Bioluminescent Reporter for Tracking Stem Cells Survival, Proliferation and Differentiation in Vivo

Tissue Engineered Medical Products

The 3Rs: are Human Stem Cells and Organs on Chip alternatives?

The Hollow Fiber Bioreactor and Cell Co-Cultivation

Discover TruPRP. PRP the way you want it.

Future implications of regenerative medicine on assisted reproductive technology. Regenerative medicine. History of Regenerative medicine

Stem Cells and Regenerative Medicine

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING PAPER REPORT ON HUMAN EMBRYONIC STEM CELL RESEARCH

Functional Assessment and Clinical Outcome

3D Cell Culture Product Intro. Bio-Byblos Biomedical

Asexu. Figure 6 A small glass tube, called a micropipette, is used to remove the nucleus from a cell and later introduce a new nucleus.

Blue Marble University Biology Course Handbook

Production Assistance for Cellular Therapies PACT

Cloning For Embryonic Stem Cells

Human embryonic stem cells for in-vitro developmental toxicity testing

Epigenetics, Environment and Human Health

Contents. The Right Surface for Every Cell Extracellular Matrices and Biologically Coated Surfaces ECM Mimetic and Advanced Surfaces...

Was it supposedly the same process that was used to create Dolly, the cloned sheep?

Stem Cell Research and Kidney Disease

What we ll do today. Types of stem cells. Do engineered ips and ES cells have. What genes are special in stem cells?

Optical Fiber Sensors for Biomedical Applications

Do engineered ips and ES cells have similar molecular signatures?

Introduction This is an exam style question on stem cells that might be useful towards the end of the topic.

8. Clinical Trial Assessment Phase II

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

ALLODERM SELECT ALLODERM SELECT RESTORE

A gateway to academic excellence for Biotech and Pharma

STEM CELLS IN NEUROLOGY ISABELLE COCHRANE MERIT

Transcription:

Promising Future for Ex vivo Tissue Fabrication Eiji Kobayashi, MD, PhD Department of Organ Fabrication, Keio University School of Medicine, Japan

The research for fabricating tissue/organs through cultivation of stem cells gathered from the patients themselves has been accelerated in recent years. Through the usage of ips cells and alike we develop various cellular tissues from the patients and multiply them on vascular beds to fabricate target tissues. In the future by maximizing microsurgical technique, newly fabricated tissues derived from the patients themselves will surely be transplantable. 2

Translational Researches Medicine Basic Science Expert Clinician Bioethics (Kobayashi E & Montero EF. Act Cri Bras 20;194,2005)

Translational Research: From rat to clinic In vivo Tissue Fabrication (Data from Dr. Shuangbai Zhou)

Cross-border academia collaboration between Prof. Li (China) and Prof. Kobayashi (Japan) `The firefly Rat` developed world-first by Prof. Kobayashi in the early years of 2000s 5

ES cell = embryonic stem cell; ips cell = induced pluripotent stem cell Possible Source for Human Organs Fertilized egg Morula Clone ES Cell Mouse 2007 Human 2013 Blastocyst ES Cell Mouse 1981 Human 1998 Unfertilized egg Enucleation Blastocyst Cell Injection ips Cell Mouse 2006 Human 2007 Somatic Cell (Oct3/4. Sox2. LIf4. C-Myc ) Yamanaka s 4 factors Reprogramming

Contribution of co-cultured endothelial cells within the construct Nat. Commun. 2013;4:1399.

`Tissue-engineered` cardiomyocytes sheet Temperature Responsive Culture Dishes developed by Prof. Okano 8

Fabrication of implantable liver tissue using bio- 3D printer and development of a novel transplantation technique for liver tissue Yusuke Yanagi 1, Tomoaki Taguchi 1,Koichi Nakayama 4,Kenichi Kohashi 5, Shin Enosawa 3, Eiji Kobayashi 2 1 Department of Pediatric Surgery, Reproductive and Developmental Medicine, Graduate School of Medical Sciences, Kyushu University 2 Department of Organ Fabrication, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan 3 National Center for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo 157-8535, Japan 4 Department of Advanced Technology Fusion,Advanced Technology Fusion, Graduate School of Science and Engineering, Saga University (Submitted) 9

Tissue Fabrication is restricted due to the limits of passive diffusion in vivo in vitro necrosis Triple layered cell sheets Tissue thickness reached a plateau at 80um New technologies for improving the reconstruction of 3D cell-dense tissue with a well organized vasculature are required.

Overcome diffusion limits by multi-step transplantation 1 day intervals Allowed for sufficient blood-vessel formation ctnt/cd31

Objective Followed by in vivo study, we hypothesized that it may be possible to overcome these diffusion limits in vitro by employing vascular bed and bioreactor system that allowed for sufficient vascular network in the engineered cardiac tissues. Imitating in vivo condition Vascular bed

Ex vivo vascular bed 10mm Muscle with femoral artery and vein

Schematic illustration of the concept used for in virto engineering of 3-D tissue with perfusable blood vessels

Multi-step overlaying of triple-layer cardiac cell sheets for scale up 4 Multi-layered cardiac tissue 3 2 Vein 1 Artery Vascular bed 12 days after perfusion culture

Methods GFP-positive endothelial cells(ecs) ( +) or ( - ) 4 days culture Layered Cardiomyocytes Cell sheets Culture medium Femoral muscle with an artery and a vein Tissue perfusion bioreactor

Bioreactor set up and tissue perfusion culture Pressure sensor Medium tank Camera Perfusion pump Electronic balance Tissue culture chamber Medium return [g] Perfusion flow rate [ul/min] Arterial pressure [mmhg] 24 48 72 [hrs]

Contribution of co-cultured endothelial cells within the engineered construct Black ink 3 days after perfusion culture G FGF-2 (-) FGF-2 (+) G G ECs (-) 50um 50um G G G ECs (+) 50um 50um

Contribution of co-cultured endothelial cells within the engineered construct Two-photon microscope images Perfused with Red fluorescent dextran or Red fluorescent 4 um spheres

Contribution of co-cultured endothelial cells within the engineered construct ECs (+) FGF-2 (+) GFP positive grafted endothelial cells GFP positive vascular bed G Border zone 20um 20um CD31 / GFP

ECs (+) FGF-2 (+) Contribution of co-cultured endothelial cells within the engineered construct GFP ECs 20 um Total ECs CD31 / GFP / DAPI

In vitro perfusable blood vessel formation and viable cardiac tissue fabrication * p<0.05 (One-way ANOVA with Fisher s LSD test) 45 min 90 min 18.3min

Double-step overlaying of triple-layer cell sheets for thick tissue formation in vitro conditions and their viability assay G * p<0.05 (Unpaired Student t test)

Transplantation of in vitro vascularized cardiac tissues 6 days H Anastomoses (+) * p<0.05 (One-way ANOVA with Fisher s LSD test) 2 weeks after transplantation 25

Why doctors are in need of pushing forward researchers? Basic (Aspect) Reality Research Translation (Possibility) Registries Research Clinical Research Guideline (Rule)

Shall we do our best for the suffering patients